Though most weight loss patches are marketed as GLP-1 patches, they do not contain a GLP-1 agonist, such as semaglutide or tirzepatide
According to the Doctors prescribe GLP-1 receptor agonists, including semaglutide and tirzepatide, to treat type 2 diabetes and obesity
Common Side Effects vs Serious Concerns When discussing GLP-1 side effects, its important to distinguish between common, manageable side effects and rare, serious concerns
Opioid receptor ligands derived from food proteins
nutrigenomic studies argue that tailoring dose and formulation to such variants can optimize outcomes and reduce pill burden (94, 95)
Available 12.5 mg/0.5 mL Available according to the FDA and were receiving no reports of supply issues